GlobeNewswire Inc.··Not SpecifiedVera Therapeutics Bolsters Board with Royalty Pharma Executive Ahead of Key Drug Launch
Vera Therapeutics appoints Christopher Hite, Royalty Pharma EVP, to board as the biotech prepares for atacicept launch in IgA nephropathy treatment.
RPRXVERAbiopharmaceuticalIgA nephropathy